CLINICAL_TRIALS
trial_result
· 2017-01-10
Clinical Trial Update: A Study of Erlotinib in Locally Advanced, Unresectable, or Metastatic Pancreatic Cancer [Phase 3]
Summary
This document reports the completion and posting of Phase 3 trial results for erlotinib in locally advanced, unresectable, or metastatic pancreatic cancer. The …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Pancreatic Cancer | Phase 3 | Status: COMPLETED | Results posted: 2017-01-10